Reproduce “PRISM2: Unlocking Multi-Modal General Pathology AI with Clinical Dialogue” on OpenResearch

Turn your favorite coding agents into research agents that review literature, develop hypotheses, and run experiments.

Universal app for Apple silicon and Intel. Requires macOS 11 or later.

About this paper

Eugene Vorontsov, George Shaikovski, Adam Casson, Julian Viret, Eric Zimmermann, Neil Tenenholtz, Yi Kan Wang, Jan H. Bernhard and 11 more

PRISM2 is a multimodal, slide-level foundation model for general pathology AI developed by Paige, Microsoft Research, Memorial Sloan Kettering Cancer Center, and Yale. It achieves clinical-grade cancer detection performance directly through question-answering and demonstrates superior generalizability across diverse diagnostic, prognostic, and biomarker tasks.

Key insights

  • Training a foundation model on massive multimodal data with sophisticated clinical dialogue supervision enables direct clinical-grade performance for diagnostic tasks without further task-specific fine-tuning.
  • The integration of large language models allows for the generation of clinically grounded representations that transfer effectively across a wide range of diagnostic, prognostic, and biomarker prediction tasks.
  • Leveraging generative AI (GPT-4o) to transform raw clinical reports into structured dialogue provides a scalable method to bridge the representational gap between histopathology images and diagnostic reasoning.

Summary by alphaXiv.

Tip: change arxiv.org to autoarxiv.org in any arXiv abstract link to open the paper here.